Rite Aid Corp (RAD)
$15.16
0.00 (0.00%)
RAD Stock Quote Delayed 30 Minutes
Previous Close
$15.16
Market Cap
16.17B
PE Ratio
-44.59
EPS
-0.34
Volume (Avg. Vol.)
675
Day's Range
15.16 - 15.16
52-Week Range
5.04 - 23.88
Dividend & Yield
N/A (N/A)
RAD Stock Predictions, Articles, and Rite Aid Corp News
Rite Aid Pulls Plug on Facial-recognition System with China Links
Rite Aid is dropping a facial-recognition technology because of its links with now-problematic Chinese firms.
A Single Exemplary Quarter Won’t Fix Rite Aid’s Problems
RAD stock spiked after fiscal first quarter earnings last month. But that good news is offset by worrisome trends facing the sector as a whole.
There Is No Good Reason to Buy Rite-Aid Stock
Rite-Aid stock isn't breaking down, but it's certainly not thriving. I don't want mediocre. I want stocks that have long-term growth plans.
Rite Aid Earnings: RAD Stock Climbs 22% Higher on Q1 Beats
Rite Aid earnings have RAD stock rising after the company beat Wall Street's expectations for revenue and per-share numbers for the quarter.
Top Stock Trades for Thursday: AMZN, APT, LAKE, RAD
Rite Aid, Alpha Pro Tech, Amazon and Lakeland Industries were our top stock trades from Wednesday. That said, let's look at the charts now.
Rite-Aid Stock Should Benefit From the Company’s Turnaround
Rite Aid stock should benefit from the company's turnaround. It's restructuring strategy will feed through to an eventual increase in Rite Aid stock.
Rite-Aid Stock Looks Well-Positioned to Climb After Its Q1 Results
Rite Aid's overly conservative comments about its outlook have made the Street underestimate the company's Q1 performance. Investors should buy Rite-Aid stock ahead of the firm's Q1 results.
Rite Aid Is Making the Right Moves During the Covid Crisis
While it hasn't yet been reflected in the RAD stock price, Rite Aid has been among the most responsive companies during the pandemic.
No Prescription Can Save Drug Store Dinosaur Rite Aid Stock
Investors are rooting for a Rite Aid turnaround, but it looks increasingly unlikely. Sell RAD stock now and look for better opportunities.
Intense Competition Still Looms Over Rite Aid Stock
RAD stock has stabilized in recent months, but Q4 results show a lack of growth. With disruption on the way, Rite Aid may be left behind.
4 Top Stock Trades for Friday: MS, SHOP, RAD, SNAP
Morgan Stanley, Shopify, Snap and Rite Aid were our top stock trades for Friday. That said, here's a look at the charts now.
Stock Market Today: New Records for Amazon, Netflix
Jobless claims data continues to paint an uninspiring outlook on the U.S. economy. Here's what happened in the stock market today.
Rite Aid Earnings: RAD Stock Plunges 19% on Greater-than-Expected Loss
Rite Aid (RAD) earnings for the drugstore company's fiscal fourth quarter of 2020 have RAD stock taking a beating on Thursday.
Is Rite Aid Stock a Buy Before This Week’s Earnings Report?
Rite Aid has been taking steps to serve customers and healthcare workers more effectively in the national battle against the outbreak. But will they translate into higher earnings in April?
Hidden Positives Behind the Risks in Rite Aid Stock
RAD stock has rallied nicely — and for good reason. While debt remains a key risk, there are positive developments worth highlighting.
Rite Aid Stock Is Breaking Out
RAD stock is on fire this week. And with a breakout apparently in the offing, $20 could be around the corner.
Navellier Ratings
Powered by Portfolio GraderTotal Grade
A
